Skip to main content
SpringerLink
Log in

Chronic Kidney Disease

  • Chapter
Clinical Decisions in Pediatric Nephrology

  • 1189 Accesses

Abstract

A 10-year old African-American girl has progressive kidney failure from biopsyproven FSGS. Her current serum creatinine is 3.7 mg/dl and estimated GFR is 16 ml/min/1.73m2. A urine protein-to-creatinine ratio is 4560 mg/g. Other medical problems include hypertension, currently treated with furosemide 40 mg orally twice daily and lisinopril 40 mg once daily. Her BP is 160/85 mmHg.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Barkis GL, Weir MR, Seic M, et al. (2004) Differential effects of calcium antagonist subclasses on markers of nephropathy progression. Kidney Int 65:1991–2002

    Article  Google Scholar 

  • Collins AJ, Li S, Gilbertson DT, et al. (2003) Chronic kidney disease and cardiovascular disease in Medicare population. Kidney Int 87:S24–S31

    Article  Google Scholar 

  • Ritz E, McClellan W (2004) Overview: Increased cardiovascular risk in patients with minor renal dysfunction: An emerging issue with far-reaching consequences. J Am Soc Nephrol 15: 513–516

    Article  PubMed  Google Scholar 

  • Romundstad S, Holmen J, Kvenlid K, et al. (2003) Microalbuminuria and all-cause mortality in 2089 apparently healthy individuals: a 4.4-yrat follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 42:466–473

    Article  PubMed  Google Scholar 

  • Muntner PLLH, Kusek JW, Chen J, et al. (2004) The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 140:9–17

    PubMed  Google Scholar 

  • Fogo AG (2003) Hypertensive risk factors in kidney disease in African Americans. Kidney Int 63:2331–2341

    Article  Google Scholar 

  • Wright JT, Glassock R, Herbet I, et al. (2002) Effect of BP lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288:2421–2431

    Article  CAS  PubMed  Google Scholar 

  • Hogg RJ, Portman RJ, Millimer D (2000) Evaluation of proteinuria and nephritic syndrome in children: Recommendations from a pediatric nephrology panel established at National Kidney Foundation conference on proteinuria, albuminuria, risk, detection, and elimination (PARDE). Pediatrics 105:1242–1249

    Article  CAS  PubMed  Google Scholar 

  • Ruggenenti P, Perna A, Remuzzi (2003) Retarding the progression of chronic renal disease: The neglected issue of residual proteinuria. Kidney Int 63:2254–2261

    Article  CAS  PubMed  Google Scholar 

  • Baigent C, Landry M (2003) Study of Heart and Renal Protection (SHARP). Kidney Int 63: S207–S210

    Article  Google Scholar 

  • Cigarroa RG, Lange RA, Williams RH (1989) Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med 86:649–652

    Article  CAS  PubMed  Google Scholar 

  • Nakao N, Yoshimma A, Morita H, et al. (2002) Combination therapy of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in non-diabetic renal disease: A randomized, controlled trial in Japan (CCPERATE). Lancet 361:117–124

    Article  Google Scholar 

  • Bakris GL, Weir MR (2000) Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine. Is this a cause for concern? Arch Intern Med 160:685–693

    Article  CAS  PubMed  Google Scholar 

  • Ecder T, Edelstein CL, Fick-Brosnahan GM, et al. (2001) Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. Am J Nephrol 21:98–103

    Article  CAS  PubMed  Google Scholar 

  • National Kidney Foundation: K/DOQI clinical guidelines for chronic kidney disease: evaluation, classification, and stratification (2002). Am J Kidney Dis 29 (Suppl 1) S1–S266

    Google Scholar 

  • Arora P, Obrador GT, Ruthazer R, et al. (1999) Prevalence, predictor, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10:1281–1286

    CAS  PubMed  Google Scholar 

  • Hales CN (2001) Suicide of the nephron. Lancet 357:136–137

    Article  CAS  PubMed  Google Scholar 

  • Keane WF (2000) Proteinuria: its clinical importance and role in progressive renal disease. Am J Kidney Dis 35:S97–S105

    Article  CAS  PubMed  Google Scholar 

  • Levey AS, Greene T, Beck GJ, et al. (1999) Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol 10:2436–2439

    Google Scholar 

  • Pedrini MT, Levey AS, Lau J, et al. (1996) The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal disease: a meta-analysis. An Intern Med 124:267–637

    Google Scholar 

  • Cameron J (1999) European best practice guidelines for the management of anemia in patients with chronic renal failure. Nephrol Dial Transplant 14:S61–S65

    Article  Google Scholar 

  • National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002). Am J Kid Dis 39:S1–S266

    Google Scholar 

  • Hayashi T, Suzuki A, Shoji T, et al. (2000) Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure. Am J Kidney Dis 35:250–256

    Article  CAS  PubMed  Google Scholar 

  • Levin A, Thompson C, Ethier J, et al. (1999) Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 34:125–134

    Article  CAS  PubMed  Google Scholar 

  • Levin A, Thompson C, Ethier J, et al. (1999) Left ventricular mass index increase in early renal disease: Impact of decline in hemoglobin. Am J Kid Dis 34:125–134

    Article  CAS  PubMed  Google Scholar 

  • Ritz E, Orth SR (1999) Nephropathy in patients with Type 2 diabetes mellitus. N Engl J Med 341:1127–1951

    Article  CAS  PubMed  Google Scholar 

  • Slatopolsky E, Burke SK, Dillon MA, et al. (1999) Renagel, a nonabsorbed calcium-and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone. Kidney Int 55:299–307

    Article  CAS  PubMed  Google Scholar 

  • Caravaca F, Arrobas M, Pizarro JL, et al. (1999) Metabolic acidosis in advanced renal failure: Differences between diabetic and nondiabetic patients. Am J Kidney Dis 33:892–898

    Article  CAS  PubMed  Google Scholar 

  • National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification (2002). Am J Kidney Dis 39: S1–S266

    Article  Google Scholar 

  • Hels CN (2001) Suicide of the nephron. Lancet 357:136–137

    Article  Google Scholar 

  • Nath K (1998) The tubulointerstitium in progressive renal disease. Kidney Int 54:992–1456

    Article  CAS  PubMed  Google Scholar 

  • Nakao N. Yoshimura A, Morita H, et al. (2003) Combination treatment of angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor in no-diabetic renal disease (CCPERATE): a randomized controlled trial. Lancet 361:117–124

    Article  CAS  PubMed  Google Scholar 

  • Dillon JJ (2001) Treating IgA nephropathy. J Am Soc Nephrol 2001; 12:846–847

    CAS  Google Scholar 

  • Ibanez L, Morlans M, Vidal X, et al. (2005) Case-control study of regular analgesic and nonsteroidal anti-inflammatory use and end-stage renal

    Google Scholar 

  • Besarab A, Bolton WK, Browne JK (1998) The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339:584–590

    Article  CAS  PubMed  Google Scholar 

  • K/DOQI Clinical Practice Guidelines on Hypertension and antihypertensive agents in chronic kidney disease (2004). Am J Kidney Dis 43:(Suppl 1) S5–S10

    Google Scholar 

  • Knoll GA, Sahgal A, Nair RC, et al. (2002) Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients. Am J Med 112:110–114

    Article  CAS  PubMed  Google Scholar 

  • Mitch WE, Remuzzi G (2004) Diets for patients with chronic kidney disease, still worth prescribing. J Am Soc Nephrol 15:234–237

    Article  PubMed  Google Scholar 

  • Weiner DE, Sarnak MJ (2004) Managing dyslipidemia in chronic kidney disease. J Gen Intern Med 19:1045–1052

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rush University Medical Center, Chicago, Illinois

    Farahnak Assadi M.D. (Professor of Pediatrics, Director, Section of Pediatric Nephrology)

Authors
  1. Farahnak Assadi M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Assadi, F. (2008). Chronic Kidney Disease. In: Clinical Decisions in Pediatric Nephrology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-74602-9_9

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-74602-9_9

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-74601-2

  • Online ISBN: 978-0-387-74602-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation